These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 28461575

  • 1. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
    Phuc NM, Wu Z, O Y, Lee JH, Oh S, Song GY, Liu KH.
    Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
    [Abstract] [Full Text] [Related]

  • 2. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
    Lee E, Wu Z, Shon JC, Liu KH.
    Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
    [Abstract] [Full Text] [Related]

  • 3. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
    Lu J, Liu D, Zhou X, Chen A, Jiang Z, Ye X, Liu M, Wang X.
    Phytomedicine; 2018 Jan 15; 39():137-145. PubMed ID: 29433675
    [Abstract] [Full Text] [Related]

  • 4. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
    Lee E, Kim JH, Shon JC, Wu Z, Kim HJ, Gim M, Lee T, Liu KH.
    Drug Metab Pharmacokinet; 2018 Jun 15; 33(3):159-163. PubMed ID: 29759885
    [Abstract] [Full Text] [Related]

  • 5. Identifying the Dominant Contribution of Human Cytochrome P450 2J2 to the Metabolism of Rivaroxaban, an Oral Anticoagulant.
    Zhao T, Chen Y, Wang D, Wang L, Dong P, Zhao S, Wang C, Meng Q, Sun H, Liu K, Wu J.
    Cardiovasc Drugs Ther; 2022 Feb 15; 36(1):121-129. PubMed ID: 33411110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
    Lee CA, Jones JP, Katayama J, Kaspera R, Jiang Y, Freiwald S, Smith E, Walker GS, Totah RA.
    Drug Metab Dispos; 2012 May 15; 40(5):943-51. PubMed ID: 22328583
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The inhibitory potential of Broussochalcone A for the human cytochrome P450 2J2 isoform and its anti-cancer effects via FOXO3 activation.
    Park SH, Lee J, Shon JC, Phuc NM, Jee JG, Liu KH.
    Phytomedicine; 2018 Mar 15; 42():199-206. PubMed ID: 29655687
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
    Bhateria M, Ramakrishna R, Puttrevu SK, Saxena AK, Bhatta RS.
    Chem Biol Interact; 2016 Aug 25; 256():257-65. PubMed ID: 27387538
    [Abstract] [Full Text] [Related]

  • 12. In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes.
    Xu S, Zhang F, Chen D, Su K, Zhang L, Jiang R.
    Pharm Biol; 2020 Dec 25; 58(1):308-313. PubMed ID: 32285742
    [Abstract] [Full Text] [Related]

  • 13. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ, Smith TJ, Murphy SE, Wang MH, Lee J, Tynes RE, Koch P, Yang CS.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):127-38. PubMed ID: 8806763
    [Abstract] [Full Text] [Related]

  • 14. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
    Wei J, Zhang H, Zhao Q.
    Pharm Biol; 2018 Dec 01; 56(1):363-367. PubMed ID: 30122094
    [Abstract] [Full Text] [Related]

  • 15. In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes.
    Li Y, Qin J, Wu H, Xu Y, Zhang L, Su K, Cui Y, Wang H.
    Pharm Biol; 2020 Dec 01; 58(1):695-700. PubMed ID: 32673137
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies.
    Wang L, Zhang D, Raghavan N, Yao M, Ma L, Frost CE, Maxwell BD, Chen SY, He K, Goosen TC, Humphreys WG, Grossman SJ.
    Drug Metab Dispos; 2010 Mar 01; 38(3):448-58. PubMed ID: 19940026
    [Abstract] [Full Text] [Related]

  • 19. Aromatic hydroxylation of salicylic acid and aspirin by human cytochromes P450.
    Bojić M, Sedgeman CA, Nagy LD, Guengerich FP.
    Eur J Pharm Sci; 2015 Jun 20; 73():49-56. PubMed ID: 25840124
    [Abstract] [Full Text] [Related]

  • 20. In vitro inhibitory effects of phellodendrine on human liver cytochrome P450 enzymes.
    Li J, Wen H, Gao Z.
    Xenobiotica; 2020 Feb 20; 50(2):231-236. PubMed ID: 31020909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.